# Mifepristone

NDC: 76346-654
Generic name: Mifepristone
Labeler / Manufacturer: Corcept Therapeutics Incorporated
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240528

FDA application: NDA202107

## Active ingredients

- MIFEPRISTONE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"76346-654"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76346-654
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=63c068cd-9370-460f-829b-70e8c7ebe91e